Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial-Reference-Cited by-同舟云学术

Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

Published:2013-09-26 Issue:9 Volume:8 Page:e75665
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gottardo Raphael,Bailer Robert T.,Korber Bette T.,Gnanakaran S.,Phillips Joshua,Shen Xiaoying,Tomaras Georgia D.,Turk Ellen,Imholte Gregory,Eckler Larry,Wenschuh Holger,Zerweck Johannes,Greene Kelli,Gao Hongmei,Berman Phillip W.,Francis Donald,Sinangil Faruk,Lee Carter,Nitayaphan Sorachai,Rerks-Ngarm Supachai,Kaewkungwal Jaranit,Pitisuttithum Punnee,Tartaglia James,Robb Merlin L.,Michael Nelson L.,Kim Jerome H.,Zolla-Pazner Susan,Haynes Barton F.,Mascola John R.,Self Steve,Gilbert Peter,Montefiori David C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference93 articles.

1. Correlates of protection induced by vaccination;SA Plotkin;Clin Vacc Immunol,2008

2. The role of antibodies in HIV vaccines;JR Mascola;Annu Rev Immunol,2010

3. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys;R Shibata;Nat Med,1999

4. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies;JR Mascola;Nat Med,2000

5. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques;AJ Hessell;Nat Med,2009

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

2. Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses;Viruses;2024-08-27

3. Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects;Viruses;2024-02-27

4. Mapping antibody footprints using binding profiles;Cell Reports Methods;2023-08

5. The Mechanism of bnAb Production and Its Application in Mutable Virus Broad-Spectrum Vaccines: Inspiration from HIV-1 Broad Neutralization Research;Vaccines;2023-06-25